![Fmoc-L-Lys[C20-OtBu-γ-Glu(OtBu)-AEEA-AEEA]-OH](/upload/2026/7/89-1.jpg "Fmoc-L-Lys[C20-OtBu-γ-Glu(OtBu)-AEEA-AEEA]-OH")
5-Bromo-4-fluoro-1-methyl-1H-indazole | CAS 1784678-61-0
- cas：1784678-61-0
- Molecular Formula：
- Purity：99%
- Molecular Weight：
This product is for research and development use only.
Product Details;
CasNo： 1784678-61-0
5-Bromo-4-fluoro-1-methyl-1H-indazole Chemical Properties
|
Boiling point |
293.4±20.0 °C(Predicted) |
|
density |
1.70±0.1 g/cm3(Predicted) |
|
pka |
-0.38±0.30(Predicted) |
|
InChI |
InChI=1S/C8H6BrFN2/c1-12-7-3-2-6(9)8(10)5(7)4-11-12/h2-4H,1H3 |
|
InChIKey |
ANLXRMBQONDZBQ-UHFFFAOYSA-N |
|
SMILES |
N1(C)C2=C(C(F)=C(Br)C=C2)C=N1 |
5-Bromo-4-fluoro-1-methyl-1H-indazole Usage And Synthesis
|
Description |
5-Bromo-4-fluoro-1-methyl-1h-indazole is an intermediate component in the synthesis of Orforglipron. Orforglipron is a small-molecule, non-peptide GLP-1 receptor agonist indicated for weight reduction and type 2 diabetes. It is currently in Phase 3 clinical trials. |
|
Uses |
5-Bromo-4-fluoro-1-methyl-1H-indazole is a crucial compound that could be used as a pharmaceutical intermediate in pharmaceutical synthesis and scientific research. |
Relevant Products
-
Fmoc-AEEACAS：166108-71-0
-
Fmoc-Ile-Aib-Leu-Asp(OtBu)-OHCAS：2915356-38-4
-
![5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-](/upload/2026/7/12-1.jpg "5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-")
-
![(S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one](/upload/2026/7/14-1.jpg "(S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one")
